Distribution parallels distribution of all biotechnology companies with main states being Victoria then New South Wales. Western Australia has disproportionately more than Queensland which suggests that they may be more fragile.
Major Sector is Human Health followed by Equipment and Services then daylight
Most companies established at turn of century or in recent years
38% of companies valued less than $20 million and 54% less than $40 million
44% of companies are less than $20 million and 58% less than $40 million (Alterity Therapeutics, Immuron, Invex Therapeutics, Nyrada and Tissue Repair are valued at less than their cash holding)
51% of companies turn over less than $2 million and 63% turn over less than $5 million
